“[Philadelphia is] an epicenter for groundbreaking cancer research and related biomedical science. We look forward to welcoming more than 18,500 laboratory cancer researchers, oncologists in a variety of disciplines, representatives from the pharmaceutical and biotechnology industries and patient advocates from around the world next April at the Pennsylvania Convention Center. This is a huge, complex scientific meeting, and SMG and the PHLCVB have been very enthusiastic, professional and responsive to our needs throughout this entire process.”

— Margaret Foti, PhD, MD, CEO, American Association for Cancer Research

“All my needs have been met and all of my expectations have been exceeded.”

 

Ken Barnes, Executive Director, Omega Psi Phi Inc.